PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Methanolic extract from leaves (MEOAL) attenuated pancreatic beta-cell and cardiac inflammation in streptozocin-induced diabetic rats [PMID:36696433]
A 1:1 combination of E. purpurea and O. acanthium reduced proinflammatory cytokines TNF-alpha and IFN-gamma in lipopolysaccharide-challenged rats [PMID:39683190]
Silver nanoparticles synthesized from O. acanthium extract exhibited significant cytotoxicity with an IC50 of 66.04 ug/mL in vitro [PMID:34817774]
Crude hydromethanolic leaf extracts showed cytotoxic effects via apoptosis (IC50 of 309 ug/ml) in vitro [PMID:26142501]
Isolated sesquiterpene lactones exhibited antiproliferative action with IC50 values between 3.6-13.5 uM in vitro [PMID:26901188]
Evidence summary
PubMed sources
- 1.PMID: 30759795 (2019) — A Traditional Medicine Plant, Onopordum acanthium L. (Asteraceae): Chemical Composition and Pharmacological Research. · Plants (Basel, Switzerland)
- 2.PMID: 25146768 (2014) — Phytotoxic potential of Onopordum acanthium L. (Asteraceae). · Chemistry & biodiversity
- 3.PMID: 37309371 (2023) — In vitro and in silico evaluation of the design of nano-phyto-drug candidate for oral use against Staphylococcus aureus. · PeerJ
- 4.PMID: 39683190 (2024) — Echinacea purpurea and Onopordum acanthium Combined Extracts Cause Immunomodulatory Effects in Lipopolysaccharide-Challenged Rats. · Plants (Basel, Switzerland)
- 5.PMID: 36696433 (2023) — Onopordum acanthium L. extract attenuates pancreatic β-Cells and cardiac inflammation in streptozocin-induced diabetic rats.